These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6398169)

  • 1. The micro-circulation in systemic sclerosis.
    Jayson MI
    Clin Exp Rheumatol; 1984; 2(1):85-91. PubMed ID: 6398169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?
    Cutolo M; Sulli A; Smith V
    Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic sclerosis--a microvascular disorder?
    Jayson MI
    J R Soc Med; 1983 Aug; 76(8):635-42. PubMed ID: 6350584
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Cutolo M
    Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
    [No Abstract]   [Full Text] [Related]  

  • 6. The vascular defect in scleroderma (systemic sclerosis).
    Leroy EC
    Acta Med Scand Suppl; 1987; 715():165-7. PubMed ID: 3495959
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphologic study of the microcirculation in connective tissue diseases].
    Cantatore FP; Corrado A; Covelli M; Lapadula G
    Ann Ital Med Int; 2000; 15(4):273-81. PubMed ID: 11202629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma: pathogenic factors and current management.
    Penny R
    Aust N Z J Med; 1978; 8 Suppl 1():143-8. PubMed ID: 365159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.
    Cannon PJ; Hassar M; Case DB; Casarella WJ; Sommers SC; LeRoy EC
    Medicine (Baltimore); 1974 Jan; 53(1):1-46. PubMed ID: 4808710
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxidative stress, microvascular dysfunction, and scleroderma: an association with potential therapeutic implications, a commentary on "Postocclusive reactive hyperemia inversely correlates with urinary 15-F2t-isoprostane levels in systemic sclerosis".
    Chung CP; Avalos I; Stein CM
    Free Radic Biol Med; 2006 May; 40(10):1698-9. PubMed ID: 16678008
    [No Abstract]   [Full Text] [Related]  

  • 11. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Galluccio F; Matucci-Cerinic M
    Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood perfusion correlates with microvascular abnormalities in systemic sclerosis: a laser-Doppler and nailfold videocapillaroscopy study.
    Cutolo M; Ferrone C; Pizzorni C; Soldano S; Seriolo B; Sulli A
    J Rheumatol; 2010 Jun; 37(6):1174-80. PubMed ID: 20436070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular manifestations of systemic sclerosis (scleroderma).
    Follansbee WP
    Curr Probl Cardiol; 1986 May; 11(5):241-98. PubMed ID: 3487417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenomenon, syndrome and disease of Maurice Raynaud.
    Belch JJ
    Br J Rheumatol; 1990 Jun; 29(3):162-5. PubMed ID: 2357495
    [No Abstract]   [Full Text] [Related]  

  • 15. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease.
    Flick JA; Boyle JT; Tuchman DN; Athreya BH; Doughty RA
    Pediatrics; 1988 Jul; 82(1):107-11. PubMed ID: 3288952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic sclerosis. A vascular perspective.
    LeRoy EC
    Rheum Dis Clin North Am; 1996 Nov; 22(4):675-94. PubMed ID: 8923590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential dermal microvascular and perivascular changes in the development of scleroderma.
    Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P
    J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
    Rusakova MS
    Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
    Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
    Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.